$PRSO

Peraso Inc. (PRSO): Results of Operations and Financial Condition

Peraso Inc. (PRSO) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 peraso_ex991.htm PRESS RELEASE peraso_ex991.htm EXHIBIT 99.1 Peraso Announces Second Quarter 2026 Results SAN JOSE, Calif., Aug. 11, 2026 – Peraso Inc. (NASDAQ: PRSO) (“Peraso” or the “Company”), a leader in high-performance 60 GHz wireless technology, today announced f

Original reporting
Published Aug 11, 2026, 8:32 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 11, 2026, 8:37 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$PRSO
Neutral
medium confidence
Mentioned
$PRSO
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$PRSONeutralMed
01

Why it matters

Traders can update expectations for near-term revenue timing (order shipment irregularity) and assess whether gross margin improvement is sustainable versus driven by mix and non-recurring items.

02

Market read

The filing provides fresh quarterly financial datapoints and a specific operational outlook that irregular order patterns may extend into Q4, which can affect revenue timing models.

03

What to watch

Management attributes gross margin improvement partly to non-recurring engineering services and inventory write-down reversals, which may not repeat in future quarters.

Relevance 7/10Novelty 7/10Timing: after-hours filing and earnings call scheduled for 1:30 p.m. PT today

Background

This is an SEC 8-K with an attached press release covering Peraso’s Q2 2026 results and management commentary on order patterns and supply constraints.

Company-level read

Ticker impact

$PRSONeutralMedium confidence
Context

Peraso reported Q2 2026 revenue of $1.3M, GAAP net loss of $2.2M, and said irregular order patterns may extend into Q4.

Expected impact

Near-term volatility likely, with upside bias from the sequential revenue and higher gross margin, offset by Q4 uncertainty around order timing and component supply.

Evidence & confidence

The filing provides concrete quarterly financials and a forward-looking operational expectation (irregular order patterns extending into Q4), which can drive revisions to near-term revenue timing and margin durability.

Market effects

Highlights demand and supply-chain sensitivity in 60 GHz mmWave fixed wireless access, which can affect sentiment toward similar RF/semiconductor suppliers.

Limited direct regional read-through; primarily company-specific execution and component availability.

Potential read-through to global fixed wireless access equipment demand timing, but details are company-specific.

Counterpoint

Sequential growth may reflect a one-time catch-up shipment of a previously delayed order, so underlying demand could still be choppy despite better gross margin.

Key entities

  • Peraso Inc.

    NASDAQ-listed 60 GHz wireless technology company reporting Q2 2026 results and commenting on irregular order patterns into Q4.

  • Ron Glibbery

    CEO quoted on sequential revenue growth, irregular order patterns, and interest from drone manufacturers.

  • Jim Sullivan

    CFO scheduled to host the earnings call.

Related articles

$PRSOMed

Peraso Enters Into Committed Equity Facility of Up to $25 Million

Peraso Inc. (NASDAQ:PRSO) said it entered a committed equity facility with Roth Principal Investments (RPI), allowing Peraso to sell up to $25 million of common stock at its discretion after a resale registration statement is filed and effective. Net proceeds would fund working capital and general corporate purposes, including product development for drone, defense, and tactical communications.

$PRSOMed

Peraso Inc.: Peraso Enters Into Committed Equity Facility of Up to $25 Million

Peraso Inc. (NASDAQ:PRSO) said it entered a committed equity facility with Roth Principal Investments, LLC, allowing it to sell up to $25 million of common stock at its discretion after a resale registration statement is filed and effective. Proceeds would support working capital and general corporate purposes, including product development for drone, defense, and tactical communications.

$MLYSMedAI 8/10

Why is Mineralys Therapeutics stock sliding today?

Investing.com reports Mineralys Therapeutics (MLYS) shares fell 4.9% in after-hours after posting a Q2 2026 per-share loss of $2.85 versus a $2.63 analyst consensus. The loss followed a rise in operating costs, including $221.4 million R&D and a $200 million upfront payment to Tanabe for lorundrostat royalty buyout. FDA PDUFA is Dec. 22, 2026.

$IAUMed

i-80 Gold Q2 Earnings Call Highlights

i-80 Gold (TSE:IAU) reported Q2 cash of about $465M (down from $514M in Q1) and Q2 revenue just over $24M. Gold production was ~11,100 oz with ~5,300 oz sold. Management said Granite Creek resource work supports a feasibility study expected in Q3 2026, while Archimedes feasibility is delayed to mid-2027; Lone Tree refurbishment remains on track for first gold by end-2027.

$INUVMed

Inuvo, Inc. (INUV): Results of Operations and Financial Condition

Inuvo, Inc. (INUV) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 4 inuvo_ex991.htm PRESS RELEASE inuvo_ex991.htm EXHIBIT 99.1 Inuvo Reports Second Quarter 2026 Results Audience Modeling Revenue Grows 19% as Company Streamlines Legacy Search and Strengthens Capital Position Management to host conference call at 4:15 PM ET, Tuesday, Augu

$SNALMedAI 9/10

Why is Snail stock plummeting today?

Investing.com reports Snail Inc. (SNAL) shares fell 30.9% in after-hours to $3.17 after Q2 2026 results missed expectations. Revenue was $19.7M, down 11.3% YoY and below a ~$29M consensus. Bookings fell 19.6% to $21.8M and net loss was $3.0M. The sell-off was company-specific.